Skip to main content
. 2023 Feb 2;12(2):140–151. doi: 10.21037/gs-22-480

Figure 1.

Figure 1

Representation of the number of patients with and without metastatic axillary LNs in each level. (A) Patients with palpable LNs, N=14. (B) Patients with non-palpable LNs and an ultrasound diagnosis of axillary involvement, N=11. LN, lymph node.